These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 30360826)

  • 21. Soluble human leukocyte antigen G5 polarizes differentiation of macrophages toward a decidual macrophage-like phenotype.
    Lee CL; Guo Y; So KH; Vijayan M; Guo Y; Wong VH; Yao Y; Lee KF; Chiu PC; Yeung WS
    Hum Reprod; 2015 Oct; 30(10):2263-74. PubMed ID: 26307092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear receptor control of opposing macrophage phenotypes in cardiovascular disease.
    Frieler RA; Ramnarayanan S; Mortensen RM
    Front Biosci (Landmark Ed); 2012 Jan; 17(5):1917-30. PubMed ID: 22201845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophages and CSF-1: implications for development and beyond.
    Jones CV; Ricardo SD
    Organogenesis; 2013 Oct; 9(4):249-60. PubMed ID: 23974218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Truncated thioredoxin (Trx-80) promotes pro-inflammatory macrophages of the M1 phenotype and enhances atherosclerosis.
    Mahmood DF; Abderrazak A; Couchie D; Lunov O; Diderot V; Syrovets T; Slimane MN; Gosselet F; Simmet T; Rouis M; El Hadri K
    J Cell Physiol; 2013 Jul; 228(7):1577-83. PubMed ID: 23335265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using High-Dimensional Approaches to Probe Monocytes and Macrophages in Cardiovascular Disease.
    Dick SA; Zaman R; Epelman S
    Front Immunol; 2019; 10():2146. PubMed ID: 31572369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage subsets in atherosclerosis as defined by single-cell technologies.
    Willemsen L; de Winther MP
    J Pathol; 2020 Apr; 250(5):705-714. PubMed ID: 32003464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic Mechanisms in Monocytes/Macrophages Regulate Inflammation in Cardiometabolic and Vascular Disease.
    Davis FM; Gallagher KA
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):623-634. PubMed ID: 30760015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2.
    Chistiakov DA; Myasoedova VA; Revin VV; Orekhov AN; Bobryshev YV
    Immunobiology; 2018 Jan; 223(1):101-111. PubMed ID: 29032836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage phenotypes in atherosclerosis.
    Colin S; Chinetti-Gbaguidi G; Staels B
    Immunol Rev; 2014 Nov; 262(1):153-66. PubMed ID: 25319333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophages: development and tissue specialization.
    Varol C; Mildner A; Jung S
    Annu Rev Immunol; 2015; 33():643-75. PubMed ID: 25861979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophages and Cardiovascular Health.
    Frodermann V; Nahrendorf M
    Physiol Rev; 2018 Oct; 98(4):2523-2569. PubMed ID: 30156496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage phenotypes in tissue repair and the foreign body response: Implications for biomaterial-based regenerative medicine strategies.
    Martin KE; García AJ
    Acta Biomater; 2021 Oct; 133():4-16. PubMed ID: 33775905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crucial role of interferon-gamma and stimulated macrophages in cardiovascular disease.
    Schroecksnadel K; Frick B; Winkler C; Fuchs D
    Curr Vasc Pharmacol; 2006 Jul; 4(3):205-13. PubMed ID: 16842138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophages: The Good, the Bad, and the Gluttony.
    Ross EA; Devitt A; Johnson JR
    Front Immunol; 2021; 12():708186. PubMed ID: 34456917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A glimpse on the phenomenon of macrophage polarization during atherosclerosis.
    Pello OM; Silvestre C; De Pizzol M; Andrés V
    Immunobiology; 2011 Nov; 216(11):1172-6. PubMed ID: 21802768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage heterogeneity in atherosclerosis: A matter of context.
    Wieland EB; Kempen LJ; Donners MM; Biessen EA; Goossens P
    Eur J Immunol; 2024 Jan; 54(1):e2350464. PubMed ID: 37943053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of IL-37 in Cardiovascular Disease Inflammation.
    Yang Z; Kang L; Wang Y; Xiang J; Wu Q; Xu C; Zhou Y; Chen S; Fang H; Liu J; Dong M
    Can J Cardiol; 2019 Jul; 35(7):923-930. PubMed ID: 31292092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended culture of macrophages from different sources and maturation results in a common M2 phenotype.
    Chamberlain LM; Holt-Casper D; Gonzalez-Juarrero M; Grainger DW
    J Biomed Mater Res A; 2015 Sep; 103(9):2864-74. PubMed ID: 25684281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?
    Parisi L; Gini E; Baci D; Tremolati M; Fanuli M; Bassani B; Farronato G; Bruno A; Mortara L
    J Immunol Res; 2018; 2018():8917804. PubMed ID: 29507865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage function and polarization in cardiovascular disease: a role of estrogen signaling?
    Bolego C; Cignarella A; Staels B; Chinetti-Gbaguidi G
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1127-34. PubMed ID: 23640494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.